Cervos Medical Secures EU MDR Certification for KeyPRP System
Cervos Medical, a dedicated subsidiary of Ranfac Corp, is thrilled to announce that its innovative CERVOS® KeyPRP System has successfully achieved certification under the European Union Medical Device Regulation EU 2017/745. This significant accomplishment confirms that the system meets the rigorous safety, performance, and quality standards set by the European Union.
Commitment to Quality and Safety
According to Michaela Gates, Quality Assurance Project Manager at Ranfac, obtaining CE certification for the Platelet Separator reflects not only compliance but also a profound commitment to safety and quality. “Our team’s hard work has truly paid off, and with this certification, we are eager to explore new market opportunities in the EU,” she stated. This marks a pivotal moment for the team and the company’s future growth.
Exclusive Distribution and Growing Opportunities
The CERVOS® KeyPRP System is designed to support healthcare providers in delivering innovative regenerative solutions. Within Europe, this system will be distributed exclusively through Aspire Medical, serving as key corporate partners helping to spearhead efforts to introduce this groundbreaking technology to new users and markets.
Expansion into European Markets
Following the certification, Eric Kreuz, Vice President of Quality Assurance and Regulatory Affairs at Ranfac, shared his insights on the future: “This certification affirms our relentless dedication to product excellence and patient safety. With the backing of Ranfac Corp, we are strategically poised to bring our leading-edge regenerative technologies to healthcare professionals and patients in various global markets.”
Leading in Advanced Autologous Tissue Processing
Cervos Medical has distinguished itself in the regenerative medicine field, focusing keenly on advanced autologous tissue processing systems. Their innovative technology plays a crucial role in various areas including platelet-rich plasma (PRP), bone marrow aspiration, and adipose tissue processing, ensuring that clinicians can achieve the best possible outcomes for their patients.
Company Background: Cervos Medical
The core mission of Cervos Medical is clear: to develop groundbreaking, minimally invasive technologies for the collection and processing of autologous tissues. As a product of Ranfac Corp, Cervos melds clinical knowledge with cutting-edge engineering to produce solutions that adhere to the highest regulatory and performance benchmarks.
Ranfac Corporation's Legacy
Ranfac Corporation, based in Avon, Massachusetts, boasts over a century of excellence in medical device manufacturing. Their extensive experience lays a strong foundation for Cervos Medical’s ongoing innovations in regenerative medicine.
Frequently Asked Questions
What is the significance of the EU MDR certification?
The EU MDR certification ensures that the CERVOS® KeyPRP System meets stringent safety and performance standards required in the European Union, enhancing trust and marketability.
Who is responsible for distributing the CERVOS® KeyPRP System in Europe?
The CERVOS® KeyPRP System will be exclusively distributed in Europe by Aspire Medical, ensuring effective market penetration and service.
What does the CERVOS® KeyPRP System do?
The CERVOS® KeyPRP System is designed to assist healthcare professionals in the collection and processing of autologous tissues such as platelet-rich plasma.
How does Cervos Medical ensure product safety?
Cervos Medical implements rigorous quality assurance processes and complies with high regulatory standards to ensure the safety and effectiveness of its medical products.
Where is Ranfac Corporation located?
Ranfac Corporation is based in Avon, Massachusetts, where it has established a legacy in the field of medical device manufacturing for over 100 years.
